Description This issue covers the latest developments in the understanding of rheumatoid arthritis at the early stage. Treatments such as with newer
biologic agents and conventional disease-modifying antirheumatic drugs are reviewed. Also included are articles on imaging modalities
as a means of identifying those in the early stages and monitoring response to treatment.
Contents 1. The Evidence of Early Intervention (Quinn) 2. Encouraging Early Referral to Rheumatologists (Cush) 3. Early Arthritis Cohorts
(Silman and Symmons) 4. Early Undifferentiated Arthritis (El-Gabalawy) 5. Early Oligoarthritis (Green and Marzo-Ortega) 6.
Early Psoriatic Arthritis (Kane) 7. Early Rheumatoid Arthritis (Young) 8. MR/US as Diagnostic Tool in Early Arthritis (Wakefield
and Conghan) 9. Value of DXA as Diagnostic and Assessment Tool in Early Arthritis (Haugeberg) 10. Radiology in Early Arthritis
(Heijde) 11. Conventional DMARDS in Early Arthritis (Mottonen) 12. Biologics in Early Arthritis (Breedveld) 13. Potential
for Altering RA Outcome (Quinn)
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company